Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
The study achieved its primary endpoint, showing that individuals who received mRNA-1283 generated a higher immune response against both the Omicron BA.4/BA.5 and original strains of SARS-CoV-2, compared to mRNA-1273.222, Moderna's previously approved bivalent Omicron BA.4/BA.5-targeting COVID vaccine. Per management, the benefit was primarily seen in older adults aged over 65 years, the population that remains at the highest risk of infection from the virus. Per Moderna, mRNA-1083 offers the potential for longer shelf life and storage advantages. However, management did not report any numerical data or figures. It intends to provide detailed data from the study at the company's vaccine day event on Mar 27. Year to date, Moderna's shares have increased 8.0% against the industry's 0.9% fall. Image Source: Zacks Investment Research The above results intend to reinforce confidence in Moderna's combination vaccines. The company is currently evaluating mRNA-1083, which combines mR
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- U.K. Tests World-First Personalized Skin Cancer Vaccine [Forbes]Forbes
- Should You Buy Moderna Before May 12? [Yahoo! Finance]Yahoo! Finance
- Sunil Wadhwa Joins Kong as Chief Customer Officer [Yahoo! Finance]Yahoo! Finance
- Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 4/26/24 - Form 4
- 4/24/24 - Form 144
- 4/19/24 - Form 4
- MRNA's page on the SEC website